{"transactions":[{"id":1665355,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PORT. STRAT & ALNCE OFCR"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2024-01-31T16:23:31.000Z","date":"2024-01-29","kind":"exercise","planned":true,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":0,"derivative":{"expiration_date":"2024-01-29","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001415889-24-002065","document":"form4-01312024_090124.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000141588924002065/form4-01312024_090124.xml","form_type":"4"}},{"id":1665354,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PORT. STRAT & ALNCE OFCR"}}],"security":"Common Stock","published_at":"2024-01-31T16:23:31.000Z","date":"2024-01-29","kind":"tax_withholding","planned":true,"acquired":false,"shares":1024,"price":4.99,"value":5109.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":14279,"source":{"system":"sec-edgar","filing":"0001415889-24-002065","document":"form4-01312024_090124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000141588924002065/form4-01312024_090124.xml","form_type":"4"}},{"id":1665353,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PORT. STRAT & ALNCE OFCR"}}],"security":"Common Stock","published_at":"2024-01-31T16:23:31.000Z","date":"2024-01-29","kind":"exercise","planned":true,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15303,"source":{"system":"sec-edgar","filing":"0001415889-24-002065","document":"form4-01312024_090124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000141588924002065/form4-01312024_090124.xml","form_type":"4"}},{"id":1665352,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PORT. STRAT & ALNCE OFCR"}}],"security":"Common Stock","published_at":"2024-01-31T16:23:31.000Z","date":"2024-01-29","kind":"sale","planned":true,"acquired":false,"shares":12185,"price":5,"value":60925.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was entered into pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 29, 2023."}],"balance_after":12803,"source":{"system":"sec-edgar","filing":"0001415889-24-002065","document":"form4-01312024_090124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000141588924002065/form4-01312024_090124.xml","form_type":"4"}},{"id":1830406,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-07-13T18:40:46.000Z","date":"2023-07-12","kind":"exercise","planned":false,"acquired":false,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total shares annually beginning on July 12, 2022, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":6500,"derivative":{"expiration_date":"2025-07-12","underlying":"Common Stock","underlying_shares":3250},"source":{"system":"sec-edgar","filing":"0001209191-23-042244","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919123042244/doc4.xml","form_type":"4"}},{"id":1830405,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Common Stock","published_at":"2023-07-13T18:40:46.000Z","date":"2023-07-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":1123,"price":4.7,"value":5278.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":24988,"source":{"system":"sec-edgar","filing":"0001209191-23-042244","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919123042244/doc4.xml","form_type":"4"}},{"id":1830404,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Common Stock","published_at":"2023-07-13T18:40:46.000Z","date":"2023-07-12","kind":"exercise","planned":false,"acquired":true,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":26111,"source":{"system":"sec-edgar","filing":"0001209191-23-042244","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919123042244/doc4.xml","form_type":"4"}},{"id":1966387,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-03-07T16:46:32.000Z","date":"2023-03-03","kind":"exercise","acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest as to 1/4th of the total shares annually beginning on March 5, 2022, subject to continued service through each vesting date."}],"balance_after":11000,"derivative":{"expiration_date":"2025-03-05","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001209191-23-016794","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919123016794/doc4.xml","form_type":"4"}},{"id":1966386,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-03-07T16:46:32.000Z","date":"2023-03-03","kind":"exercise","acquired":false,"shares":6750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest as to 1/4th of the total shares annually beginning on March 4, 2023, subject to continued service through each vesting date."}],"balance_after":20250,"derivative":{"expiration_date":"2026-03-04","underlying":"Common Stock","underlying_shares":6750},"source":{"system":"sec-edgar","filing":"0001209191-23-016794","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919123016794/doc4.xml","form_type":"4"}},{"id":1966385,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-03-07T16:46:32.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest as to 1/4th of the total shares annually beginning on March 1, 2024, subject to continued service through each vesting date."}],"balance_after":25000,"derivative":{"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-23-016794","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919123016794/doc4.xml","form_type":"4"}},{"id":1966384,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2023-03-07T16:46:32.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to 2.0833% of the total shares monthly, beginning on April 1, 2023, with 100% of the total shares vested and exercisable on March 1, 2027, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":35000,"derivative":{"exercise_price":5.79,"expiration_date":"2033-02-28","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-23-016794","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919123016794/doc4.xml","form_type":"4"}},{"id":1966383,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Common Stock","published_at":"2023-03-07T16:46:32.000Z","date":"2023-03-03","kind":"tax_withholding","acquired":false,"shares":4990,"price":5.79,"value":28892.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":22861,"source":{"system":"sec-edgar","filing":"0001209191-23-016794","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919123016794/doc4.xml","form_type":"4"}},{"id":1966382,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Common Stock","published_at":"2023-03-07T16:46:32.000Z","date":"2023-03-03","kind":"exercise","acquired":true,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."}],"balance_after":27851,"source":{"system":"sec-edgar","filing":"0001209191-23-016794","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919123016794/doc4.xml","form_type":"4"}},{"id":1966381,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Common Stock","published_at":"2023-03-07T16:46:32.000Z","date":"2023-03-03","kind":"exercise","acquired":true,"shares":6750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."}],"balance_after":22351,"source":{"system":"sec-edgar","filing":"0001209191-23-016794","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919123016794/doc4.xml","form_type":"4"}},{"id":2040506,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-01-31T17:24:34.000Z","date":"2023-01-27","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date."}],"balance_after":2500,"derivative":{"expiration_date":"2024-01-29","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-23-005757","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919123005757/doc4.xml","form_type":"4"}},{"id":2040505,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Common Stock","published_at":"2023-01-31T17:24:34.000Z","date":"2023-01-27","kind":"tax_withholding","acquired":false,"shares":1019,"price":7.5,"value":7642.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":15601,"source":{"system":"sec-edgar","filing":"0001209191-23-005757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919123005757/doc4.xml","form_type":"4"}},{"id":2040504,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Common Stock","published_at":"2023-01-31T17:24:34.000Z","date":"2023-01-27","kind":"exercise","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16620,"source":{"system":"sec-edgar","filing":"0001209191-23-005757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919123005757/doc4.xml","form_type":"4"}},{"id":2208140,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2022-07-13T18:24:34.000Z","date":"2022-07-12","kind":"exercise","acquired":false,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total shares annually beginning on July 12, 2022, subject to continued service through each vesting date."}],"balance_after":9750,"derivative":{"expiration_date":"2025-07-12","underlying":"Common Stock","underlying_shares":3250},"source":{"system":"sec-edgar","filing":"0001209191-22-042072","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919122042072/doc4.xml","form_type":"4"}},{"id":2208139,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Common Stock","published_at":"2022-07-13T18:24:34.000Z","date":"2022-07-12","kind":"tax_withholding","acquired":false,"shares":1123,"price":6.08,"value":6827.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":14120,"source":{"system":"sec-edgar","filing":"0001209191-22-042072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919122042072/doc4.xml","form_type":"4"}},{"id":2208138,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Common Stock","published_at":"2022-07-13T18:24:34.000Z","date":"2022-07-12","kind":"exercise","acquired":true,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15243,"source":{"system":"sec-edgar","filing":"0001209191-22-042072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919122042072/doc4.xml","form_type":"4"}},{"id":2348325,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2022-03-07T19:23:42.000Z","date":"2022-03-05","kind":"exercise","acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest as to 1/4th of the total shares annually beginning on March 5, 2022, subject to continued service through each vesting date."}],"balance_after":16500,"derivative":{"expiration_date":"2025-03-05","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001209191-22-016855","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919122016855/doc4.xml","form_type":"4"}},{"id":2348324,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2022-03-07T19:23:42.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest as to 1/4th of the total shares annually beginning on March 4, 2023, subject to continued service through each vesting date."}],"balance_after":27000,"derivative":{"expiration_date":"2026-03-04","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001209191-22-016855","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919122016855/doc4.xml","form_type":"4"}},{"id":2348323,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2022-03-07T19:23:42.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to 2.0833% of the total shares monthly, beginning on April 4, 2022, with 100% of the total shares vested and exercisable on March 4, 2026, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":36000,"derivative":{"exercise_price":8.17,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001209191-22-016855","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919122016855/doc4.xml","form_type":"4"}},{"id":2348322,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Common Stock","published_at":"2022-03-07T19:23:42.000Z","date":"2022-03-05","kind":"tax_withholding","acquired":false,"shares":2253,"price":8.17,"value":18407.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":11993,"source":{"system":"sec-edgar","filing":"0001209191-22-016855","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919122016855/doc4.xml","form_type":"4"}},{"id":2348321,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Common Stock","published_at":"2022-03-07T19:23:42.000Z","date":"2022-03-05","kind":"exercise","acquired":true,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."}],"balance_after":14246,"source":{"system":"sec-edgar","filing":"0001209191-22-016855","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919122016855/doc4.xml","form_type":"4"}},{"id":2419504,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2022-02-01T20:39:15.000Z","date":"2022-01-29","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date."}],"balance_after":5000,"derivative":{"expiration_date":"2025-01-29","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-22-006129","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919122006129/doc4.xml","form_type":"4"}},{"id":2419503,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Common Stock","published_at":"2022-02-01T20:39:15.000Z","date":"2022-01-29","kind":"tax_withholding","acquired":false,"shares":1024,"price":10.39,"value":10639.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":8746,"source":{"system":"sec-edgar","filing":"0001209191-22-006129","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919122006129/doc4.xml","form_type":"4"}},{"id":2419502,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Common Stock","published_at":"2022-02-01T20:39:15.000Z","date":"2022-01-29","kind":"exercise","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9770,"source":{"system":"sec-edgar","filing":"0001209191-22-006129","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919122006129/doc4.xml","form_type":"4"}},{"id":2557849,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2021-09-28T18:59:39.000Z","date":"2021-09-24","kind":"exercise","acquired":false,"shares":5969,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest as to 1/3rd of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date."}],"balance_after":0,"derivative":{"expiration_date":"2021-09-26","underlying":"Common Stock","underlying_shares":5969},"source":{"system":"sec-edgar","filing":"0001209191-21-057982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919121057982/doc4.xml","form_type":"4"}},{"id":2557848,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Common Stock","published_at":"2021-09-28T18:59:39.000Z","date":"2021-09-28","kind":"sale","acquired":false,"shares":3906,"price":18.6186,"value":72724.2516,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $18.47 to $19.08 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7270,"source":{"system":"sec-edgar","filing":"0001209191-21-057982","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919121057982/doc4.xml","form_type":"4"}},{"id":2557847,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Common Stock","published_at":"2021-09-28T18:59:39.000Z","date":"2021-09-24","kind":"tax_withholding","acquired":false,"shares":2063,"price":19.23,"value":39671.49,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person."}],"balance_after":11176,"source":{"system":"sec-edgar","filing":"0001209191-21-057982","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919121057982/doc4.xml","form_type":"4"}},{"id":2557846,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":94773,"kind":"person","name":"Vasquez Nicki","position":1,"cik":"0001877585","reported_name":"Vasquez Nicki","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Port. Strat & Alnce Ofcr"}}],"security":"Common Stock","published_at":"2021-09-28T18:59:39.000Z","date":"2021-09-24","kind":"exercise","acquired":true,"shares":5969,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13239,"source":{"system":"sec-edgar","filing":"0001209191-21-057982","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877585/000120919121057982/doc4.xml","form_type":"4"}}]}